NL-OMON45433
Completed
Not Applicable
The effect of duodenal, ileal or combined infusion of tastants on food intake - The effect of tastants on food intake
Medisch Universitair Ziekenhuis Maastricht0 sites19 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obesity
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 19
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Based on medical history and previous examination, no gastrointestinal complaints can be defined.
- •\- Age between 18 and 65 years. This study will include healthy adult subjects (male and female).
- •\- BMI between 18 and 25 kg/m2\)
- •\- Weight stable over at least the last 6 months
Exclusion Criteria
- •\- History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/psychiatric diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol. The severity of the disease (major interference with the execution of the experiment or potential influence on the study outcomes) will be decided by the principal investigator.
- •\- Use of medication, including vitamin supplementation, except oral contraceptives, within 14 days prior to testing
- •\- Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
- •\- Major abdominal surgery interfering with gastrointestinal function (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgement of the principle investigator)
- •\- Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological dynamic)
- •\- Pregnancy, lactation
- •\- Excessive alcohol consumption (\>20 alcoholic consumptions per week)
- •\- Weight \<60kg
- •\- Non\-tasters of sweet, bitter or umami
- •\- Evidence of MSG\-hypersensitivity or Chinese restaurant syndrome
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effects of orally and intraduodenally administered pea protein on satiety parameters in vivo in lean and obese subjects.Obesitasoverweight10003018NL-OMON34022niversiteit Maastricht24
Completed
Not Applicable
The Effect of Duodenal, Ileal or Combined Infusion of Tastants on Food IntakeObesityNCT03140930Maastricht University Medical Center19
Completed
Not Applicable
The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese IndividualsObesityNCT02880813University of Michigan8
Completed
Not Applicable
Regional glucose infusion on gut functioGlucose metabolismMetabolic and Endocrine - Normal metabolism and endocrine development and functionMetabolic and Endocrine - DiabetesACTRN12615001240538Royal Adelaide Hospital32
Completed
Not Applicable
Effects of intraduodenal versus intragastric administration of quinine on gut function in healthy, lean volunteers.Healthy human gastrointestinal physiologyDiet and Nutrition - ObesityObesityType 2 DiabetesOral and Gastrointestinal - Normal oral and gastrointestinal development and functionMetabolic and Endocrine - DiabetesACTRN12619000707167Christine Feinle-Bisset28